FUJIFILM Biotechnologies Capabilities Update May 2026: Mammalian Cell Culture

FUJIFILM Biotechnologies is a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines and advanced therapies. With over 30 years of experience, the Company specializes in developing and manufacturing biopharmaceuticals using microbial, mammalian, and host/virus systems.

With over 5,000 employees, FUJIFILM Biotechnologies operates a fully integrated, kojoX global network with major facilities in the United States, the United Kingdom, and Denmark. The Company’s kojoX manufacturing network ensures supply chain agility for its customers through modular facilities and standardized processes for seamless scaling and technology transfers.

FUJIFILM Biotechnologies offers comprehensive services, ranging from proprietary cell line development, to process and analytical development, and through to clinical and commercial manufacturing.